Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

Past Auctions

Sale #3: Global Online Auction of Late Model Equipment From Clinical Stage Biopharmaceutical Facility! Manchester & Alderley Edge, UK.

Starting: Apr 2nd, 2024 7:00am BST

Ending: Apr 3rd, 2024 10:00am BST

Immediately Accepting Bids
Online Auction Featuring Late Model Lab Equipment Assets Surplus To Future Needs Of A CDMO! Gainesville, FL.

Starting: Mar 21st, 2024 7:00am EDT

Ending: Mar 22nd, 2024 12:00pm EDT

Immediately Accepting Bids
Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Apr 18th, 2024 7:00am PDT

Ending: Apr 19th, 2024 9:00am PDT

Immediately Accepting Bids
Sale #5: Online Auction Featuring State of the Art Lab Equipment Surplus To Future Needs of Invitae! Morrisville, NC.

Starting: Feb 12th, 2024 7:00am EST

Ending: Feb 13th, 2024 10:00am EST

Immediately Accepting Bids
The 133rd Sale Featuring State Of The Art Biopharma R&D Lab Equipment From The World’s Premier Pharmaceutical Manufacturer!

Starting: Apr 23rd, 2024 7:00am EDT

Ending: Apr 25th, 2024 12:00pm EDT

Immediately Accepting Bids
Online Auction Sale #2 Of Complete Pharmaceutical Facility Focused On Production of Hematology & Immunology Drugs. Solna, Sweden.

Starting: Feb 6th, 2024 1:00pm CET

Ending: Feb 7th, 2024 11:00am CET

Immediately Accepting Bids
Online Auction Featuring Quality Biologics Manufacturing and Lab Equipment From A Leading CDMO! Tustin, CA.

Starting: Mar 19th, 2024 7:00am PDT

Ending: Mar 20th, 2024 9:00am PDT

Immediately Accepting Bids
Online Auction Featuring Quality Pharmaceutical Process & Manufacturing Equipment Surplus To Future Needs of VistaPharm. Largo, FL.

Starting: Feb 27th, 2024 7:00am EST

Ending: Feb 28th, 2024 12:00pm EST

Immediately Accepting Bids
Online Auction Featuring Late Model Biotech Lab Equipment From One of Biogen’s Reata Sites! Irving, TX.

Starting: Feb 22nd, 2024 7:00am CST

Ending: Feb 23rd, 2024 10:00am CST

Immediately Accepting Bids
Online Auction Featuring Late Model R&D Equipment Formerly Of MolecularDX! Windber, PA.

Starting: Jan 11th, 2024 7:00am EST

Ending: Jan 12th, 2024 12:00pm EST

Immediately Accepting Bids
Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Mar 11th, 2024 7:00am PDT

Ending: Mar 12th, 2024 9:00am PDT

Immediately Accepting Bids
The 132nd Sale Featuring State Of The Art Biopharma R&D Lab Equipment From The World’s Premier Pharmaceutical Manufacturer!

Starting: Mar 26th, 2024 7:00am EDT

Ending: Mar 28th, 2024 10:00am EDT

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.